KRT19 and hepatocellular carcinoma: Zhang et al. (2021) discovered a link between the proportion of mesenchymal CTCs and CK19 expression, with higher mesenchymal CTCs reported in CK19-positive patients, which was linked with a worse prognosis in HCC patients [33].